| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes T Aasen, A Raya, MJ Barrero, E Garreta, A Consiglio, F Gonzalez, ... Nature biotechnology 26 (11), 1276-1284, 2008 | 1929 | 2008 |
| The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling MT Epping, L Wang, MJ Edel, L Carlée, M Hernandez, R Bernards Cell 122 (6), 835-847, 2005 | 495 | 2005 |
| Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats CR Draper, MJ Edel, IM Dick, AG Randall, GB Martin, RL Prince The Journal of nutrition 127 (9), 1795-1799, 1997 | 226 | 1997 |
| Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells A Sánchez-Danés, A Consiglio, Y Richaud, I Rodríguez-Pizà, B Dehay, ... Human gene therapy 23 (1), 56-69, 2012 | 146 | 2012 |
| Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1 MJ Edel, C Menchon, S Menendez, A Consiglio, A Raya, JCI Belmonte Genes & Development 24 (6), 561-573, 2010 | 109 | 2010 |
| iPS-cell technology and the problem of genetic instability—Can it ever be safe for clinical use? SW Attwood, MJ Edel Journal of clinical medicine 8 (3), 288, 2019 | 85 | 2019 |
| Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency S Menendez, S Camus, A Herreria, I Paramonov, LB Morera, M Collado, ... Aging cell 11 (1), 41-50, 2012 | 63 | 2012 |
| The cell cycle inhibitor p27Kip1 controls self-renewal and pluripotency of human embryonic stem cells by regulating the cell cycle, Brachyury and Twist C Menchón, MJ Edel, JC Izpisua Belmonte Cell Cycle 10 (9), 1435-1447, 2011 | 61 | 2011 |
| Potential role of induced pluripotent stem cells (IPSCs) for cell-based therapy of the ocular surface RP Casaroli-Marano, N Nieto-Nicolau, EM Martínez-Conesa, M Edel, ... Journal of clinical medicine 4 (2), 318-342, 2015 | 46 | 2015 |
| Effects of the post-spinal cord injury microenvironment on the differentiation capacity of human neural stem cells derived from induced pluripotent stem cells C López-Serrano, A Torres-Espín, J Hernández, AB Alvarez-Palomo, ... Cell transplantation 25 (10), 1833-1852, 2016 | 43 | 2016 |
| Bioengineered Bruch's-like extracellular matrix promotes retinal pigment epithelial differentiation S McLenachan, E Hao, D Zhang, L Zhang, M Edel, F Chen Biochemistry and biophysics reports 10, 178-185, 2017 | 41 | 2017 |
| mRNA transfection of mouse and human neural stem cell cultures S McLenachan, D Zhang, ABA Palomo, MJ Edel, FK Chen PLoS One 8 (12), e83596, 2013 | 39 | 2013 |
| Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis B Alvarez-Palomo, LI Sanchez-Lopez, Y Moodley, MJ Edel, ... Stem cell research & therapy 11, 1-12, 2020 | 36 | 2020 |
| Human-induced neural and mesenchymal stem cell therapy combined with a curcumin nanoconjugate as a spinal cord injury treatment P Bonilla, J Hernandez, E Giraldo, MA González-Pérez, A Alastrue-Agudo, ... International journal of molecular sciences 22 (11), 5966, 2021 | 32 | 2021 |
| Myogenic precursors from iPS cells for skeletal muscle cell replacement therapy I Roca, J Requena, MJ Edel, AB Alvarez-Palomo Journal of clinical medicine 4 (2), 243-259, 2015 | 30 | 2015 |
| iPS cells for modelling and treatment of retinal diseases FK Chen, S McLenachan, M Edel, L Da Cruz, PJ Coffey, DA Mackey Journal of clinical medicine 3 (4), 1511-1541, 2014 | 27 | 2014 |
| Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration AB Alvarez Palomo, S McLenachan, FK Chen, L Da Cruz, RJ Dilley, ... Fibrogenesis & tissue repair 8, 1-9, 2015 | 26 | 2015 |
| Integrin cytoplasmic domain‐associated protein‐1 (ICAP‐1) promotes migration of myoblasts and affects focal adhesions B Alvarez, PJM Stroeken, MJ Edel, E Roos Journal of cellular physiology 214 (2), 474-482, 2008 | 25 | 2008 |
| The ETS-related factor TEL is regulated by angiogenic growth factor VEGF in HUVE-cells. MJ Edel Anticancer research 18 (6A), 4505-4509, 1998 | 24 | 1998 |
| Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases MJ Edel, JM Harvey, JM Papadimitriou Clinical & experimental metastasis 18, 695-702, 2000 | 23 | 2000 |
